EyePoint Pharmaceuticals Registered (Old) WKN: A2JHLC ISIN: US30233G1004 Kürzel: PV3A

Ist hier noch wer

Rockt

– U.S. commercial launch trajectory for DEXYCU® and YUTIQ® gains momentum with strong customer order growth over Q2 – – DEXYCU customer orders increased 207% over Q2 with repeat customers representing 74% of order volume – – YUTIQ customer orders up 17% over Q2 with repeat customers representing 85% of order volume and prior to effective date of permanent J-Code – – Announced access to large integrated payor networks including U.S. Department of Veterans Affairs Federal Supply Schedule and Vizient Inc. Network – https://www.benzinga.com/pressreleases/19/11/g14753045/eyepoint-pharmaceuticals-reports-third-quarter-2019-financial-results-and-highlights-recent-corpor

WL

Was ist den hier passiert :D

Wird das hier der nächste gewinner? Jemand dabei?

Hallo noch irgendwer hier ? Was haltet hier von dem Ding hier ?✌

+20% gibt es news?

Aber die amerikanische Community scheint trotzdem nicht überzeugt zu sein, da das Unternehmen wohl noch kein gutes regelmäßiges Einkommen hat

PSDV will be announcing major research updates during November.Revenues and licensing partnerships are increasing substantially.At less than $47 million in market cap, pSivida is a sleeping giant with market disruptor technology. pSivida (NASDAQ:PSDV) recently announced the date, November 7, 2017, for its first quarter fiscal year 2018